Annual Accounts Payable
$3.17 M
-$2.97 M-48.35%
30 June 2024
Summary:
MEI Pharma annual accounts payable is currently $3.17 million, with the most recent change of -$2.97 million (-48.35%) on 30 June 2024. During the last 3 years, it has fallen by -$3.19 million (-50.15%). MEIP annual accounts payable is now -59.99% below its all-time high of $7.92 million, reached on 30 June 2022.MEIP Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$976.00 K
-$2.19 M-69.19%
30 September 2024
Summary:
MEI Pharma quarterly accounts payable is currently $976.00 thousand, with the most recent change of -$2.19 million (-69.19%) on 30 September 2024. Over the past year, it has dropped by -$2.24 million (-69.69%). MEIP quarterly accounts payable is now -88.48% below its all-time high of $8.47 million, reached on 30 September 2021.MEIP Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MEIP Accounts Payable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -48.4% | -69.7% |
3 y3 years | -50.1% | -88.5% |
5 y5 years | -33.8% | -68.5% |
MEIP Accounts Payable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -60.0% | at low | -88.5% | at low |
5 y | 5 years | -60.0% | +30.0% | -88.5% | at low |
alltime | all time | -60.0% | +1550.0% | -88.5% | +1034.9% |
MEI Pharma Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $976.00 K(-69.2%) |
June 2024 | $3.17 M(-48.4%) | $3.17 M(-0.3%) |
Mar 2024 | - | $3.18 M(+130.5%) |
Dec 2023 | - | $1.38 M(-57.2%) |
Sept 2023 | - | $3.22 M(-47.5%) |
June 2023 | $6.13 M(-22.5%) | $6.13 M(+39.8%) |
Mar 2023 | - | $4.39 M(+7.9%) |
Dec 2022 | - | $4.07 M(-51.7%) |
Sept 2022 | - | $8.42 M(+6.3%) |
June 2022 | $7.92 M(+24.6%) | $7.92 M(-4.1%) |
Mar 2022 | - | $8.26 M(+32.0%) |
Dec 2021 | - | $6.26 M(-26.2%) |
Sept 2021 | - | $8.47 M(+33.3%) |
June 2021 | $6.36 M(+160.8%) | $6.36 M(+14.1%) |
Mar 2021 | - | $5.57 M(+0.3%) |
Dec 2020 | - | $5.55 M(-12.9%) |
Sept 2020 | - | $6.38 M(+161.6%) |
June 2020 | $2.44 M(-49.1%) | $2.44 M(-2.2%) |
Mar 2020 | - | $2.49 M(-18.0%) |
Dec 2019 | - | $3.04 M(-1.9%) |
Sept 2019 | - | $3.10 M(-35.3%) |
June 2019 | $4.79 M(+31.4%) | $4.79 M(+143.1%) |
Mar 2019 | - | $1.97 M(-8.8%) |
Dec 2018 | - | $2.16 M(+38.8%) |
Sept 2018 | - | $1.55 M(-57.3%) |
June 2018 | $3.64 M(+522.7%) | $3.64 M(+189.4%) |
Mar 2018 | - | $1.26 M(+15.6%) |
Dec 2017 | - | $1.09 M(+45.0%) |
Sept 2017 | - | $751.00 K(+28.4%) |
June 2017 | $585.00 K(-45.8%) | $585.00 K(+141.7%) |
Mar 2017 | - | $242.00 K(-36.6%) |
Dec 2016 | - | $382.00 K(-49.0%) |
Sept 2016 | - | $749.00 K(-30.6%) |
June 2016 | $1.08 M(+25.0%) | $1.08 M(+131.5%) |
Mar 2016 | - | $466.00 K(+4.0%) |
Dec 2015 | - | $448.00 K(+77.1%) |
Sept 2015 | - | $253.00 K(-70.7%) |
June 2015 | $863.00 K(-49.5%) | $863.00 K(-68.2%) |
Mar 2015 | - | $2.71 M(+26.0%) |
Dec 2014 | - | $2.15 M(+93.7%) |
Sept 2014 | - | $1.11 M(-35.0%) |
June 2014 | $1.71 M | $1.71 M(+144.0%) |
Mar 2014 | - | $700.00 K(-13.5%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2013 | - | $809.00 K(+45.2%) |
Sept 2013 | - | $557.00 K(+3.7%) |
June 2013 | $537.00 K(-9.6%) | $537.00 K(+1.7%) |
Mar 2013 | - | $528.00 K(+17.9%) |
Dec 2012 | - | $448.00 K(-15.9%) |
Sept 2012 | - | $533.00 K(-10.3%) |
June 2012 | $594.00 K(+81.1%) | $594.00 K(+34.7%) |
Mar 2012 | - | $441.00 K(+15.7%) |
Dec 2011 | - | $381.00 K(+15.1%) |
Sept 2011 | - | $331.00 K(+0.9%) |
June 2011 | $328.00 K(-38.0%) | $328.00 K(-53.0%) |
Mar 2011 | - | $698.00 K(-9.1%) |
Dec 2010 | - | $768.00 K(+0.4%) |
Sept 2010 | - | $765.00 K(+44.6%) |
June 2010 | $529.00 K(-44.7%) | $529.00 K(-30.4%) |
Mar 2010 | - | $760.00 K(+19.7%) |
Dec 2009 | - | $635.00 K(-50.0%) |
Sept 2009 | - | $1.27 M(+32.7%) |
June 2009 | $957.00 K(-15.3%) | $957.00 K(-13.9%) |
Mar 2009 | - | $1.11 M(+61.2%) |
Dec 2008 | - | $690.00 K(-3.2%) |
Sept 2008 | - | $713.00 K(-36.9%) |
June 2008 | $1.13 M(-5.6%) | $1.13 M(+6.0%) |
Mar 2008 | - | $1.07 M(+22.5%) |
Dec 2007 | - | $870.00 K(-29.0%) |
Sept 2007 | - | $1.23 M(+2.4%) |
June 2007 | $1.20 M(+185.0%) | $1.20 M(+39.2%) |
Mar 2007 | - | $860.00 K(+6.8%) |
Dec 2006 | - | $805.00 K(+330.5%) |
Sept 2006 | - | $187.00 K(-55.5%) |
June 2006 | $420.00 K(+65.4%) | $420.00 K(+200.0%) |
Mar 2006 | - | $140.00 K(-49.6%) |
Dec 2005 | - | $278.00 K(-16.8%) |
Sept 2005 | - | $334.00 K(+31.5%) |
June 2005 | $254.00 K(+32.3%) | $254.00 K(+0.4%) |
Mar 2005 | - | $253.00 K(+19.3%) |
Dec 2004 | - | $212.00 K(+146.5%) |
Sept 2004 | - | $86.00 K(-55.2%) |
June 2004 | $192.00 K(-55.7%) | $192.00 K(+37.1%) |
Mar 2004 | - | $140.00 K(-84.9%) |
Dec 2003 | - | $926.00 K(+104.4%) |
Sept 2003 | - | $453.00 K(+4.6%) |
June 2003 | $433.00 K | $433.00 K |
FAQ
- What is MEI Pharma annual accounts payable?
- What is the all time high annual accounts payable for MEI Pharma?
- What is MEI Pharma annual accounts payable year-on-year change?
- What is MEI Pharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for MEI Pharma?
- What is MEI Pharma quarterly accounts payable year-on-year change?
What is MEI Pharma annual accounts payable?
The current annual accounts payable of MEIP is $3.17 M
What is the all time high annual accounts payable for MEI Pharma?
MEI Pharma all-time high annual accounts payable is $7.92 M
What is MEI Pharma annual accounts payable year-on-year change?
Over the past year, MEIP annual accounts payable has changed by -$2.97 M (-48.35%)
What is MEI Pharma quarterly accounts payable?
The current quarterly accounts payable of MEIP is $976.00 K
What is the all time high quarterly accounts payable for MEI Pharma?
MEI Pharma all-time high quarterly accounts payable is $8.47 M
What is MEI Pharma quarterly accounts payable year-on-year change?
Over the past year, MEIP quarterly accounts payable has changed by -$2.24 M (-69.69%)